INTL CONG OF VIROLOGY, PARIS

点击翻译按钮获取中文摘要

DESCRIPTION (provided by applicant): The American Society for Virology (ASV) requests funds to provide partial support for the travel of selected outstanding junior virologists to participate in the 12th International Congress of Virology (ICV) to be held 27 July - 1 Aug 2002 in Paris, France. The ICV is a unique opportunity for junior investigators to meet and interact directly with internationally recognized expert virologists as well as learn in plenary sessions, workshops, and poster sessions about the most recent developments in all areas of virological research, including viruses of animals, insects, plants and prokaryotes. Current problems in clinical virology and AIDS are included. Plenary sessions will cover viral emergence, evolution, immunobiology, pathogenesis, molecular biology, disease control, and viral structure and assembly. Workshops and posters address all virus families and their replication and pathogenesis, including HIV, hepatitis, and influenza viruses. The ASV recognizes the critical need to support the future of virus research and its application to demanding problems in many different areas of biology and medicine. One excellent way to stimulate and aid junior researchers in their future work is to enable them to interact directly with the best virologists world-wide, from which unique, long-lasting collaborations often result. The ICV has long provided exposure and stimulation unequaled in any other international virological meeting. Current funding limitations will make it difficult or impossible for many junior virologists to attend this Congress. The ASV President will appoint a Selection Committee to judge who will receive partial travel support based upon (1) participation in the Congress, (2) the prospect that the awardee?s research will benefit, and (3) financial need. A report detailing the benefits to their research is required. Our aim is to provide partial funding for junior virologists who might otherwise be unable to attend the Congress, with the goal of benefiting virological research in the USA for years to come. Virological research has many applications in the fields of infectious, immunologic, neoplastic, hematologic, pulmonary, cardiovascular, gastrointestinal, neurologic, ophthalmologic, developmental and childhood diseases, and in chronic and degenerative diseases, as well as in basic genetics, genomics, gene therapy, and biotechnology.